The selective Tie2 inhibitor rebastinib blocks recruitment and function of Tie2Hi macrophages in breast cancer and pancreatic neuroendocrine tumors - Harney, A S; Karagiannis, G S; Pignatelli, J (Mol Cancer Ther, 2017)